Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
The days of off-label speculation may soon be over for patients with the rare autoimmune…
You’re reading the web version of DC Diagnosis, STAT’s twice-weekly newsletter about health and medical…
Andrew Bohm, M.D., chief strategist at Pfizer, is leaving his position two years after joining…
Arizona-based Ultomiris achieves excellent results in clinical trial for rare kidney disease IgAN
By healthadmin
AstraZeneca’s Ultomiris, already approved for the treatment of four rare diseases, has also shown potential…
WASHINGTON – The Trump administration will ask states to create new plans to verify health…
Researchers have developed a powerful new imaging technique that reveals ultrafast phenomena in the microscopic…
After winning two clinical trials for intractable and early-stage kidney cancer, Merck & Co.’s blockbuster…
People systematically underestimate how often things go wrong in the world. Researchers call this the…
Researchers at the XPANCEO Emerging Technologies Research Center, in collaboration with Nobel Prize winner Professor…
Get the health information and medications you need every weekday with STAT’s free newsletter Morning…